4 completed. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 4 |
Follow Small Fiber Neuropathy: new trials by email Literature Review of Small Fiber Neuropathy trials Research Report on Small Fiber Neuropathy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Nicotinamide Riboside in Prevention of Small Fiber Axon Degeneration and Promotion of Nerve Regeneration Nicotinamide riboside, Placebo Oral Tablet - Small Fiber Neuropathy | Phase 2 | Completed | Johns Hopkins University | 45 | 2020-09-01 | 2024-06-12 |
| IVIg for Small Fiber Neuropathy With Autoantibodies TS-HDS and FGFR3 Intravenous immunoglobulin, 0.9% Sodium Chloride - Small Fiber Neuropathy, Idiopathic Peripheral Neuropathy | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 20 | 2018-09-01 | 2023-09-13 |
| A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy VX-150, Placebo - Small Fiber Neuropathy | Phase 2 | Completed | Vertex Pharmaceuticals Incorporated | 89 | 2017-09-20 | 2021-11-15 |
| Intravenous Immunoglobulin Therapy for Small Fiber Neuropathy Intravenous Immunoglobulin, Placebo - Small Fiber Neuropathy | Phase 2 | Completed | Academisch Ziekenhuis Maastricht | 60 | 2016-07-01 | 2019-07-05 |
Nervous System Diseases (4) · Neuromuscular Diseases (4) · Peripheral Nervous System Diseases (4)
Immunoglobulins, Intravenous (2) · Sodium Chloride (2) · nicotinamide-beta-riboside (1)
Academisch Ziekenhuis Maastricht (1) · Beth Israel Deaconess Medical Center (1) · Johns Hopkins University (1) · Vertex Pharmaceuticals Incorporated (1)
United States (3) · Netherlands (2) · Germany (1) · Italy (1)
Ahmet Hoke (1) · Catharina G Faber, MD, PhD (1) · Christopher Gibbons, MD (1)
2015 (1), 2017 (1)